VEGFA and neoplasm: Furthermore, VEGF-dependent release of thromboxane A2 (TXA2) by endothelial cells can trigger calcium transients in tumor cells, leading to prostaglandin E2 (PGE2) secretion and promoting tumor immune evasion (177).